| Baseline | 12 weeks | 1 month after childbirth |
---|---|---|---|
Primary outcome | Â | Â | Â |
HAMD | + | + | + |
Secondary outcome | Â | Â | Â |
MINI | + | + | + |
EPDS | + | + | + |
BDI-II | + | + | + |
Plasma | + | + | + |
Serum | + | + | + |
Other measures | Â | Â | Â |
Demographics | + | Â | Â |
Obstetric outcomes | Â | Â | + |
Erythrocyte | + | + | + |
Adverse effects | Â | + | + |